Another slip up by India in the trade pact with the U.K.

There is a dilution of India’s backing of the more effective compulsory licensing to address the high prices of patented medicines

Another slip up by India in the trade pact with the U.K.
There is a dilution of India’s backing of the more effective compulsory licensing to address the high prices of patented medicines